← Company intelligence

Robot maker · registered

Zimmer Biomet (ROSA Robotics)

Corporate marketmedicalCurated record

Scoped entry: covers only Zimmer Biomet's surgical robotics program (ROSA Robotics portfolio and the acquired Monogram autonomous orthopedic robotics line). Jobs, news and milestones are filtered by scope keywords; Zimmer Biomet's parent-wide implant/orthopedics business data is not tracked.

ROSA Knee with OptimiZe (FDA 510(k) November 2025) adds proprietary algorithmic surgical planning that personalizes implant positioning to surgeon preference, automated kinematic alignment, pinless motion-sensitive tracking, and integration with ZBEdge Analytics for data-driven intraoperative decisions, cutting planning time by about 46%. ROSA Shoulder (FDA cleared February 2024) is the world's first robotic assistant for shoulder replacement, supporting anatomic and reverse techniques with Signature ONE preoperative 3D planning. The acquired Monogram technology is a CT-based, semi-autonomous, AI-navigated TKA robot (FDA 510(k) March 2025); clinical studies of the fully autonomous version began in July 2025, with commercialization on Zimmer Biomet implants expected by early 2027.

HeadquartersWarsaw, US
Founded1927
Corporate fundingNot disclosed
TeamNot listed
Deployments3
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StagePublic (NYSE: ZBH)
FoundersNot listed
Regions servedNorth America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Countries deployedNot listed
Service footprintNot listed
Last reviewed2026-07-21
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Monogram mBos TKA System

  • CT-based, semi-autonomous, AI-navigated total knee arthroplasty robot; FDA 510(k) cleared March 2025; clinical studies of the fully autonomous version began July 2025; commercialization with Zimmer Biomet implants expected by early 2027

    Acquired with Monogram Technologies (transaction completed October 7, 2025, ~$177M plus CVRs)

    Claim source
Machinemedical

ROSA Hip System

  • Personalized robotic-assisted total hip replacement

    Vendor product-line description on official ROSA Robotic Solutions page

    Claim source
Machinemedical

ROSA Knee System (with OptimiZe)

  • Robotic-assisted total knee arthroplasty with OptimiZe Planning: personalized implant positioning from surgeon preferences via proprietary algorithms (~46% planning-time reduction), automated kinematic alignment, pinless motion-sensitive tracking, and ZBEdge Analytics integration for data-driven intraoperative decisions

    FDA 510(k)-cleared enhanced version announced November 14, 2025; U.S. availability expected Q1 2026

    Claim source
Machinemedical

ROSA ONE Brain / Spine

  • Robotic platform providing assistance in planning and performing minimally invasive complex neurosurgical and spinal procedures

    Vendor product-line description; platform originated with Zimmer Biomet's 2016 acquisition of Medtech SA (ROSA's original developer)

    Claim source
Machinemedical

ROSA Partial Knee

  • Robotic-assisted partial knee replacement within the ROSA platform

    Vendor product-line description on official ROSA Robotic Solutions page

    Claim source
Machinemedical

ROSA Shoulder System

  • World's first robotic assistant for shoulder replacement surgery; supports anatomic and reverse techniques with precise implant placement, preoperative integration with Signature ONE 2.0 3D surgical planning and real-time intraoperative data

    FDA 510(k) cleared February 2024; fourth application in the ROSA Robotics portfolio

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-06-18Temecula Valley Hospital (Southwest Healthcare)hospitalUSNot disclosedAnnouncement
2025-09-24Southlake HealthhospitalCANot disclosedAnnouncement
2024-04-25Mayo ClinichospitalUSNot disclosedAnnouncement
TL

Company timeline

Milestones and announcements

2025-11-14FDA 510(k) clearance of ROSA Knee with OptimiZe algorithmic personalized planning; ROSA platform installed base approaching 2,000 systems worldwidePR Newswire (Zimmer Biomet)
2025-10-07Completed ~$177M acquisition of Monogram Technologies, adding an FDA-cleared semi-autonomous AI-navigated TKA robot and a pathway to the first fully autonomous orthopedic robotic technologyPR Newswire (Zimmer Biomet)
2024-02-22FDA 510(k) clearance of ROSA Shoulder, the world's first robotic assistant for shoulder replacement surgery (fourth ROSA application)PR Newswire (Zimmer Biomet)
SC

Source ledger

7 unique public sources